OC50.F COCHLEAR LTD ADR 1/2/O.N.

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
42.60 EUR
Close of Nov 12, 2026
19.80 79.66
Market cap
EUR 5.57B
P/E
70.8x
P/B
5.69x
ROE
8.5%
Dividend yield
2.25%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is OC50.F undervalued?

Graham number

The Graham number of COCHLEAR LTD ADR 1/2/O.N. cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

COCHLEAR LTD ADR 1/2/O.N. fundamental analysis

No fundamental analysis for COCHLEAR LTD ADR 1/2/O.N. yet.

COCHLEAR LTD ADR 1/2/O.N. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About COCHLEAR LTD ADR 1/2/O.N.

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools. The company also provides Cochlear connected care solutions, such as Cochlear Nucleus SmartNav System; Cochlear Custom Sound Pro Fitting Software; Cochlear Remote Assist…

Full company profile